2023
DOI: 10.1002/adma.202302323
|View full text |Cite
|
Sign up to set email alerts
|

DNA‐Programmed Stem Cell Niches via Orthogonal Extracellular Vesicle–Cell Communications

Abstract: Extracellular vesicles (EVs) are natural carriers for intercellular transfer of bioactive molecules, which have been harnessed for wide biomedical applications. However, a facile yet general approach to engineering interspecies EV‐cell communications is still lacking. Here, w e report the use of DNA to encode the heterogeneous interfaces of EVs and cells in a manner free of covalent or genetic modifications, which enables orthogonal EV‐cell interkingdom interactions in complex environments. W e employ choleste… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 71 publications
0
2
0
Order By: Relevance
“…Compared to synthetic nanoparticles, EVs as naturally occurring vesicles possess evolutionary selection advantages, rendering them attractive alternative vehicles for cargo delivery. EVs have excellent biocompatibility, desired nanoscopic size, low immunogenicity, and the ability to overcome biological barriers. , The remarkable features of EVs enable them to deliver endogenous functional components as well as to carry exogenous drugs, driving the development of EV-based therapies and bioengineering. However, the full potential of EVs has not yet been realized, mainly due to their poor controllability and limited cellular delivery capacity.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Compared to synthetic nanoparticles, EVs as naturally occurring vesicles possess evolutionary selection advantages, rendering them attractive alternative vehicles for cargo delivery. EVs have excellent biocompatibility, desired nanoscopic size, low immunogenicity, and the ability to overcome biological barriers. , The remarkable features of EVs enable them to deliver endogenous functional components as well as to carry exogenous drugs, driving the development of EV-based therapies and bioengineering. However, the full potential of EVs has not yet been realized, mainly due to their poor controllability and limited cellular delivery capacity.…”
Section: Introductionmentioning
confidence: 99%
“… 2 , 3 The remarkable features of EVs enable them to deliver endogenous functional components as well as to carry exogenous drugs, driving the development of EV-based therapies and bioengineering. 4 6 However, the full potential of EVs has not yet been realized, mainly due to their poor controllability and limited cellular delivery capacity.…”
Section: Introductionmentioning
confidence: 99%